UCB

The user is receiving harassing calls related to UCB, a real agency, despite their hospital account showing no debt. They suspect their stepdad's medical debt might be involved, but no official communications from UCB have been received. The user is unsure if the calls are a scam.

United Community Banks Inc. reported Q2 profit of $115.6 million with 95 cents per share in earnings, but adjusted results of 71 cents per share and $279.3 million in revenue net of interest expense missed Wall Street expectations. Analysts had predicted 80 cents per share and $281.6 million in revenue.

UCB is acquiring a maker of antibody treatments for autoimmune diseases, amidst tighter immigration policies in the US affecting international scientists and new funding for gene therapy startup Latus Bio. The acquisition highlights UCB's interest in expanding its portfolio of treatments for autoimmune diseases. This move may impact the biotech industry.

Two drugmakers, Danco Laboratories and GenBioPro, have asked the US Supreme Court to restore mail-order access to the abortion pill mifepristone, while UCB has acquired Candid Therapeutics in a deal worth $2.2 billion to expand its presence in autoimmune disease therapies.